The U.S. Department of Agriculture’s Agricultural Research Service (ARS) today announced that an African Swine Fever Virus vaccine candidate has been adapted to grow in a cell line, which means that those involved in vaccine production will no longer have to rely on live pigs and their fresh cells for vaccine production.
Click here for original story, African swine fever virus vaccine candidate now produced in a cell line
Source: Phys.org